Investment analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Friday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Shares of NASDAQ:ATHX opened at $0.00 on Friday. The stock has a market cap of $61,719.00, a P/E ratio of 0.00 and a beta of -0.90. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99.
About Athersys
Want More Great Investing Ideas?
Featured Stories
- Five stocks we like better than Athersys
- Dividend Capture Strategy: What You Need to Know
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Choose Top Rated Stocks
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
